Effectiveness and safety of ertugliflozin for type 2 diabetes: A meta‐analysis of data from randomized controlled trials

AIMS/INTRODUCTION: To evaluate the effectiveness and safety of the novel sodium–glucose cotransporter inhibitor, ertugliflozin, compared with a placebo or other antihyperglycemic agents for type 2 diabetes patients. MATERIALS AND METHODS: We carried out a meta‐analysis of randomized controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fudan, Wang, Wenting, Hou, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902385/
https://www.ncbi.nlm.nih.gov/pubmed/34610204
http://dx.doi.org/10.1111/jdi.13688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902385/
https://www.ncbi.nlm.nih.gov/pubmed/34610204
http://dx.doi.org/10.1111/jdi.13688

Ejemplares similares